EP.13D.09 Characteristics and Survival in Never-Smoking Small Cell Lung Cancer Cases an Analysis from the Thoracic Tumor Registry

Autor: Candal-Pedreira, C., Ruano-Ravina, A., Calvo de Juan, V., Cobo, M., Trigo, J.M., Rodríguez-Abreu, D., Estival, A., Carcereny, E., Cucurull, M., López Castro, R., Medina, A., García Campelo, R., Cordeiro González, P., Sánchez-Gastaldo, A., Bosch-Barrera, J., Massutí, B., Dómine, M., Camps, C., Ortega, A.L., Provencio, M.

Publikováno v: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S678-S678

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies

Autor: Cucurull M, Notario L, Sanchez-Cespedes M, Hierro C, Estival A, Carcereny E, Saigí M

Publikováno v: Frontiers in Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Approximately 20% of lung adenocarcinomas harbor KRAS mutations, an oncogene that drives tumorigenesis and has the ability to alter the immune system and the tumor immune microenvironment. While KRAS was considered "undruggable" for decades, specific

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::09db1cc4f947201fbae04c5703d3e618
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5187

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

Autor: Pinato, DJ, Aguilar-Company, J, Ferrante, D, Hanbury, G, Bower, M, Salazar, R, Mirallas, O, Sureda, A, Plaja, A, Cucurull, M, Mesia, R, Townsend, S, Jackson, A, Dalla Pria, A, Newsom-Davis, T, Handford, J, Sita-Lumsden, A, Apthorp, E, Vincenzi, B, Bertuzzi, A, Brunet, J, Lambertini, M, Maluquer, C, Pedrazzoli, P, Biello, F, Sinclair, A, Bawany, S, Khalique, S, Rossi, S, Rogers, L, Murphy, C, Belessiotis, K, Carmona-Garcia, MC, Sharkey, R, Garcia-Illescas, D, Rizzo, G, Perachino, M, Saoudi-Gonzalez, N, Doonga, K, Fox, L, Roldan, E, Gaidano, G, Ruiz-Camps, I, Bruna, R, Patriarca, A, Martinez-Vila, C, Cantini, L, Zambelli, A, Giusti, R, Mazzoni, F, Caliman, E, Santoro, A, Grosso, F, Parisi, A, Queirolo, P, Aujayeb, A, Rimassa, L, Prat, A, Tucci, M, Libertini, M, Grisanti, S, Mukherjee, U, Diamantis, N, Fusco, V, Generali, D, Provenzano, S, Gennari, A, Tabernero, J, Cortellini, A

Publikováno v: LANCET ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19 during the omicron outbreak compared with the prevaccination period and alpha (B.1.1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4a67786bb4e1096fb306c45ffab05396
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7192

Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine

Autor: Felip, E, Hernandez, A, Notario, L, Cucurull, M, Quirant, B, Saigi, M, Gomez-Castella, R, Estevez-Macas, E, Fonollosa, SC, Bertral, PT, Costa, EC, Domenech, M, Estival, A, Paradis, AL, Badia, AP, Marin, MR, Bueno, MTM

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::fa8948aa298d49f08c6ac18f331c66fb
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1850

Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?

Autor: Plaja, A, Moran, T, Carcereny, E, Saigi, M, Hernandez, A, Cucurull, M, Domenech, M

Publikováno v: International Journal of Molecular Sciences
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Small-cell lung cancer (SCLC) is an aggressive malignancy characterized by a rapid progression and a high resistance to treatments. Unlike other solid tumors, there has been a scarce improvement in emerging treatments and survival during the last yea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d8843b0848e6292fe4be74e6d5c562ec
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4491